Rafael L. Piccolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rafael L. Piccolo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ana Flávia Marques Pereira
Botucatu Medical School (FMB), São Paulo State University (UNESP—Universidade Estadual Paulista), Botucatu 18618-687, SP, Brazil
1 shared publication - Anne Grace Andrade da Cunha Marques
Post Graduate Program in Tropical Medicine (PPGMT), Amazonas State University, Manaus 69065-001, AM, Brazil
1 shared publication - Beatriz Jacob
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, São Paulo, Brazil
1 shared publication - Felipe Augusto Cerni
Medical School, Federal University of Roraima (UFRR), Boa Vista 69310-000, Roraima, Brazil
1 shared publication - Guilherme Melo-Dos-Santos
Graduate Program in Bioscience and Biotechnology Applied to Pharmacy, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 19060-900, Brazil
1 shared publication - Isabela Gobbo Ferreira
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 19040-903, Brazil
1 shared publication
Latest Publications
- Open Access
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Investigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Open AccessInvestigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.